For instance, mutations related to tyrosine-protein kinase kit, encoded by the KIT gene, can confer chemoresistance (Wichmann et al., 2015) and negatively impact the overall survival prognosis in t(8;21)-positive acute myeloid leukemias (Krauth et al., 2014). The gene discussed is KIT; the disease is acute myeloid leukemia.